Astellas Says First-Half Profit Jumped 17& to 51.3 Billion Yen

Astellas Pharma Inc., Japan’s third-largest drugmaker, reported first-half profit increased 17 percent to 51.3 billion yen in a statement to the Tokyo Stock Exchange today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.